Clinical trial
Hydroxychloroquine Assessment of Management Study in Coronary Artery Disease After Angiography.
NCT02874287 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxychloroquine Assessment of Management Study in Coronary Artery Disease After Angiography.
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 8, 2017
- Completion date
- June 1, 2019
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.